Pasithea Therapeutics Cor...

NASDAQ: KTTA · Real-Time Price · USD
0.73
0.03 (3.89%)
At close: Aug 18, 2025, 3:54 PM
0.71
-2.86%
Pre-market: Aug 19, 2025, 07:40 AM EDT

Pasithea Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.92M 16.33M 33.15M 52.97M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -11.1M -20.12K
Receivables
n/a 40.5K 302.13K n/a
Inventory
n/a -40.5K n/a n/a
Other Current Assets
142.94K 145.21K 124.32K n/a
Total Current Assets
7.37M 16.69M 34.08M 53.3M
Property-Plant & Equipment
122.34K 220.48K 1.25M 20.12K
Goodwill & Intangibles
8.57M 9.2M 9.85M n/a
Total Long-Term Assets
8.7M 9.42M 11.1M 20.12K
Total Assets
16.06M 26.12M 45.18M 53.32M
Account Payables
n/a 2.55M 1.48M 447.28K
Deferred Revenue
n/a n/a -1.61M n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
1.12M n/a 235.88K n/a
Total Current Liabilities
1.12M 2.63M 1.88M 447.28K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
162.17K 84.37K 460.19K 1.45M
Total Long-Term Liabilities
162.17K 84.37K 804.21K 1.45M
Total Liabilities
1.28M 2.72M 2.68M 1.9M
Total Debt
n/a 81.68K 926.89K n/a
Common Stock
139.00 104.00 17.99K 17.68K
Retained Earnings
-49.58B -35.32M -19.36M -2.21M
Comprehensive Income
-7.17M -4.65K -661 -10.56K
Shareholders Equity
14.78B 23.4M 42.5M 51.42M
Total Investments
6.92B n/a n/a n/a